Catalysts for $ABBV

VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval

VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval

VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approval

ORIAHNN (COPACKAGED) (ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE) — FDA approval

ORILISSA (ELAGOLIX SODIUM) — FDA approval

Imprimis NJOF, LLC recall (Cls III)

PRED MILD (PREDNISOLONE ACETATE) — FDA approval

LINZESS (LINACLOTIDE) — FDA approval

IMBRUVICA (IBRUTINIB) — FDA approval

IMBRUVICA (IBRUTINIB) — FDA approval

IMBRUVICA (IBRUTINIB) — FDA approval

RINVOQ (UPADACITINIB) — FDA approval

RINVOQ LQ (UPADACITINIB) — FDA approval

ESCITALOPRAM OXALATE — FDA approval

QULIPTA (ATOGEPANT) — FDA approval

SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval

SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval

RINVOQ (UPADACITINIB) — FDA approval

HUMIRA (ADALIMUMAB) — FDA approval

QULIPTA (ATOGEPANT) — FDA approval

QULIPTA (ATOGEPANT) — FDA approval

SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval

SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval

DEPAKOTE (DIVALPROEX SODIUM) — FDA approval

RINVOQ (UPADACITINIB) — FDA approval

RINVOQ (UPADACITINIB) — FDA approval

RINVOQ LQ (UPADACITINIB) — FDA approval

QULIPTA (ATOGEPANT) — FDA approval